Comparison between biosimilar filgrastim vs other granulocyte‐colony stimulating factor formulations (originator filgrastim, peg‐filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 293-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

By Tan Hiangkiat   Tomic Karen   Hurley Dana   Daniel Gregory   Barron Rich   Malin Jen  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 79-86

Informa Healthcare

Access to resources Recommend Favorite

Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials

By Pinto Lionel   Liu Zhimei   Doan Quan   Bernal Myriam   Dubois Robert   Lyman Gary  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2283-2295

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 283-284

Karger

Access to resources Recommend Favorite

Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 391-397

Karger

Access to resources Recommend Favorite